A Sonoresponsive and NIR‐II‐Photoresponsive Nanozyme for Heterojunction‐Enhanced “Three‐in‐One” Multimodal Oncotherapy
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202302190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Lang Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Toxicology, Faculty of Naval Medicine, Naval Medical University, Shanghai, 200433, China. Hauptthemen laut MEDLINE: Hyperthermia, Induced, Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Social Development Science and Technology Research Project of Shanghai, Innovation Action Plan of Shanghai Science and Technology.
Abstract (Originalsprache)
Although low‐cost nanozymes with excellent stability have demonstrated the potential to be highly beneficial for nanocatalytic therapy (NCT), their unsatisfactory catalytic activity accompanied by intricate tumor microenvironment (TME) significantly hinders the therapeutic effect of NCT. Herein, for the first time, a heterojunction (HJ)‐fabricated sonoresponsive and NIR‐II‐photoresponsive nanozyme is reported by assembling carbon dots (CDs) onto TiCN nanosheets. The narrow bandgap and mixed valences of Ti 3+ and Ti 4+ endow TiCN with the capability to generate reactive oxygen species (ROS) when exposed to ultrasound (US), as well as the dual enzyme‐like activities of peroxidase and glutathione peroxidase. Moreover, the catalytic activities and sonodynamic properties of the TiCN nanosheets are boosted by the formation of HJs owing to the increased speed of carrier transfer and the enhanced electron–hole separation. More importantly, the introduction of CDs with excellent NIR‐II photothermal properties could achieve mild hyperthermia (43 °C) and thereby further improve the NCT and sonodynamic therapy (SDT) performances of CD/TiCN. The synergetic therapeutic efficacy of CD/TiCN through mild hyperthermia‐amplified NCT and SDT could realize “three‐in‐one” multimodal oncotherapy to completely eliminate tumors without recurrence. This study opens a new avenue for exploring sonoresponsive and NIR‐II‐photoresponsive nanozymes for efficient tumor therapy based on semiconductor HJs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Toxicology, Faculty of Naval Medicine, Naval Medical University, Shanghai, 200433, China.
- Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
- School of Basic Medicine, Anhui Medical University, Hefei, Anhui, 230032, China.
- School of Environmental and Chemical Engineering, Shanghai University, Shanghai, 200444, China.
- Depanrtment of Urology, the Third Affiliated Hospital of Naval Military Medical University (Eastern Hepatobiliary Surgery Hospital), Shanghai, 201805, China.
- College of Chemistry and Chemical Engineering, Dezhou University, University West Road 566, Dezhou, Shandong, 253023, China.
ORCID-Profile: Lang Yan, Lijun Ren, Jikuai Chen, Bijiang Geng
Förderung
- National Natural Science Foundation of China
- Social Development Science and Technology Research Project of Shanghai
- Innovation Action Plan of Shanghai Science and Technology
- Clinical Research Project of Shanghai Municipal Commission of Health and Family Planning
Zitieren
APA
Yan, L., Cao, Z., Ren, L., Zhang, T., Hu, J., Chen, J., Zhang, X., Liu, B., Feng, C., Zhu, J., & Geng, B. (2024). A Sonoresponsive and NIR‐II‐Photoresponsive Nanozyme for Heterojunction‐Enhanced “Three‐in‐One” Multimodal Oncotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202302190
Vancouver
Yan L, Cao Z, Ren L, Zhang T, Hu J, Chen J, et al. A Sonoresponsive and NIR‐II‐Photoresponsive Nanozyme for Heterojunction‐Enhanced “Three‐in‐One” Multimodal Oncotherapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202302190
BibTeX
@article{Yan2024,
author = {Yan, Lang and Cao, Zhi and Ren, Lijun and Zhang, Tiantian and Hu, Jinyan and Chen, Jikuai and Zhang, Xiaofang and Liu, Bing and Feng, Chuanqi and Zhu, Jiangbo and Geng, Bijiang},
title = {A Sonoresponsive and NIR‐II‐Photoresponsive Nanozyme for Heterojunction‐Enhanced “Three‐in‐One” Multimodal Oncotherapy},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202302190}
}
EUVIMED